A prospective, 30 day observational study to characterize the dietary intakes of patients treated with sacrosidase (Sucraid; QOL Medical) for Sucrose-isomaltase deficiency and determine relationships between type of carbohydrates, sacrosidase dose, and gastrointestinal symptoms
Latest Information Update: 17 Oct 2019
At a glance
- Drugs Sacrosidase (Primary)
- Indications Sucrase-isomaltase deficiency
- Focus Therapeutic Use
Most Recent Events
- 17 Oct 2019 New trial record